Oroxylin a Inhibits the Protection of Bone Marrow Microenvironment on CML Cells Through CXCL12/CXCR4/P-gp Signaling Pathway. This evidence concerns the gene CXCL12 and chronic myelogenous leukemia, BCR-ABL1 positive.